Could heart patients ditch blood thinners after a year? new trial investigates
NCT ID NCT06742931
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether people with chronic heart disease and a high risk of bleeding can stop taking antiplatelet drugs (blood thinners) one year after a balloon angioplasty procedure. Researchers will compare those who stop versus those who continue the medication, tracking major bleeding events and heart-related outcomes over time. The trial aims to enroll 1,200 participants across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antiplatelet agent discontinuation (no drug given; intervention is stopping medication)
- What this could lead to
- If successful, this could show that some heart patients can safely stop taking blood thinners after a year, lowering their risk of serious bleeding.
- What could go wrong
- This is an early-stage trial with no phase designation, and stopping blood thinners might increase the risk of heart attacks or clots. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ajou University School of Medicine
RECRUITINGSuwon, South Korea
-
Catholic Kwandong University International St. Mary's Hospital
RECRUITINGIncheon, South Korea
-
Chonbuk National University Hospital and Chonbuk National University Medical School
RECRUITINGJeonju, South Korea
-
Chonnam National University Hospital, Chonnam National University Medical School
RECRUITINGGwangju, South Korea
-
Chung-Ang University Gwangmyeong Hospital
RECRUITINGGwangmyeong, South Korea
-
Chung-Ang University Hospital
RECRUITINGSeoul, South Korea
-
Gachon Cardiovascular Research Institute, Gachon University
RECRUITINGIncheon, South Korea
-
Gangneung Asan Hospital, University of Ulsan College of Medicine
RECRUITINGGangneung, South Korea
-
Gyeongsang National University Hospital
RECRUITINGJinju, South Korea
-
Ilsan Paik hospital
RECRUITINGGoyang, South Korea
-
Inha University Hospital
RECRUITINGIncheon, South Korea
-
Kangbuk Samsung Hospital
RECRUITINGSeoul, South Korea
-
Keimyung University Dongsan Medical Center
RECRUITINGDaegu, South Korea
-
Korea University Ansan Hospital
RECRUITINGAnsan, South Korea
-
Korea University Guro Hospital
RECRUITINGSeoul, South Korea
-
SMG-SNU Boramae Medical Center
RECRUITINGSeoul, South Korea
-
Samsung Medical Center
RECRUITINGSeoul, South Korea
-
Uijeongbu St. Mary Hospital
RECRUITINGUijeongbu-si, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a higher dose of adenosine sharpen heart scans?
- Can a trained eye match ultrasound for heart stent placement?
- Could a quicker, cheaper scan replace the gold standard for heart blood flow?
- Could a neck ultrasound replace heart CT scans for chest pain patients?
- Fish oil derivative may calm heart inflammation and stabilize plaques
- Heart stent mystery: new diagnostic strategy could reveal hidden causes of Post-PCI angina